← Back to Cases
PMCPA Case

AUTH/2419/7/11: Publisher/Editor v Boehringer Ingelheim (Mirapexin/Sifrol tweet) — No breach (outwith scope)

📅 2011 | 🖉 Dr Anzal Qurbain
📊

Key facts

⌄
Case numberAUTH/2419/7/11
ComplainantPublisher/Editor
CompanyBoehringer Ingelheim
Product(s)Mirapexin/Sifrol
MaterialTweet
Complaint received07 July 2011
Completed31 August 2011
ReviewNo case report as outwith the scope of the Code
Applicable Code year2012
BreachNo breach, outwith the scope of the Code
Sanctions appliedUndertaking received
Additional sanctionsNot stated

Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

⌄
  • A complaint was made by a Publisher/Editor against Boehringer Ingelheim.
  • The matter related to a Mirapexin/Sifrol tweet.
  • The PMCPA concluded the case was outwith the scope of the Code.
⚖️

Outcome

⌄
  • No breach (outwith the scope of the Code).
  • Case completed on 31 August 2011.
  • No case report was published because it was outwith scope.
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access
← All Cases Book a Free Compliance Call

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training